Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic Petroleum | ATLADKK | Oct 31, 2024 | 2.26 | +1.80 |
Audientes | AUDNTS | Oct 31, 2024 | 0.02 | -3.80 |
Bactiquant | BACTIQ | Oct 31, 2024 | 4.42 | 0.00 |
Bang & Olufsen | BO | Oct 31, 2024 | 9.19 | +1.55 |
Bavarian Nordic | BAVA | Oct 31, 2024 | 214.70 | -1.87 |
Better Collective A/S | BETCODKK | Oct 31, 2024 | 89.40 | +0.45 |
BioPorto | BIOPOR | Oct 31, 2024 | 1.95 | 0.00 |
Boozt | BOOZTDKK | Oct 31, 2024 | 76.35 | -1.74 |
Brain+ | BRAINP | Oct 31, 2024 | 0.10 | +10.64 |
Brd. Klee B | KLEEB | Oct 31, 2024 | 3 840.00 | 0.00 |
Brdr. A & O Johansen Pref B | AOJB | Oct 31, 2024 | 81.00 | +0.87 |
Brøndbyernes IF Fodbold | BIF | Oct 31, 2024 | 0.51 | +0.39 |
Carlsberg A | CARLA | Oct 31, 2024 | 940.00 | -1.67 |
Carlsberg B | CARLB | Oct 31, 2024 | 755.00 | +0.53 |
cBrain | CBRAIN | Oct 31, 2024 | 174.60 | -1.36 |
Cemat | CEMAT | Oct 31, 2024 | 1.07 | -2.73 |
Cessatech A/S | CESSA | Oct 31, 2024 | 13.95 | +2.95 |
ChemoMetec | CHEMM | Oct 31, 2024 | 400.00 | -2.01 |
Coloplast B | COLOB | Oct 31, 2024 | 855.20 | -2.24 |
Columbus | COLUM | Oct 31, 2024 | 10.80 | +0.93 |
Conferize | CONFRZ | Oct 31, 2024 | 0.01 | +6.25 |
Copenhagen Capital | CPHCAPST | Oct 31, 2024 | 5.00 | -0.99 |
Copenhagen Capital 40 pct Pref 2032 | CPHCAPPREF32 | Oct 31, 2024 | 8.30 | 0.00 |
CS Medica | CSMED | Oct 31, 2024 | 4.24 | +0.24 |
D/S Norden | DNORD | Oct 31, 2024 | 235.20 | +1.99 |
Danish Aerospace Company | DAC | Oct 31, 2024 | 3.62 | 0.00 |
Danske Andelskassers Bank | DAB | Oct 31, 2024 | 12.75 | -0.78 |
Danske Bank | DANSKE | Oct 31, 2024 | 202.20 | +3.14 |
Dantax | DANT | Oct 31, 2024 | 454.00 | -4.22 |
Dataproces Group | DATA | Oct 31, 2024 | 5.80 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.